{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Group+1+Standard+of+Care&page=77", "query": { "intervention": "Group 1 Standard of Care", "page": 77 }, "page_size": 10 }, "pagination": { "page": 77, "page_size": 10, "total_count": 1950, "total_pages": 195, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Group+1+Standard+of+Care&page=78&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Group+1+Standard+of+Care&page=76&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T16:51:18.990Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06553534", "title": "Situation Awareness Incorporating Multidisciplinary Teams Reduce Arrests In the Pediatric ICU", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "In-hospital Cardiac Arrest", "Cardiopulmonary Resuscitation" ], "interventions": [ { "name": "SAMURAI PICU Bundle", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 5, "start_date": "2024-01-01", "completion_date": "2029-01", "has_results": false, "last_update_posted_date": "2024-08-16", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 5, "location_summary": "Chicago, Illinois • Akron, Ohio • Charleston, South Carolina + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Akron", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" }, { "city": "Richmond", "state": "Virginia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06553534" }, { "nct_id": "NCT00621192", "title": "Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Necrotizing Enterocolitis", "Intra-abdominal Infection" ], "interventions": [ { "name": "meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Emmes Company, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "90 Days", "sex": "ALL", "summary": "Up to 90 Days" }, "enrollment_count": 200, "start_date": "2008-06", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2023-04-25", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Oakland, California • Orange, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621192" }, { "nct_id": "NCT06047028", "title": "Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Ischemic Heart Disease (IHD)", "Myocardial Viability" ], "interventions": [], "intervention_types": [], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "20 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2023-07-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06047028" }, { "nct_id": "NCT01881412", "title": "Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone", "type": "DRUG" }, { "name": "Standard Asthma Discharge Instructions", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Rhode Island Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 118, "start_date": "2012-08", "completion_date": "2018-04", "has_results": true, "last_update_posted_date": "2020-05-18", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT01881412" }, { "nct_id": "NCT02296567", "title": "Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Age Related Macular Degeneration" ], "interventions": [ { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Control Group", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "East Florida Eye Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 80, "start_date": "2014-12", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2015-08-11", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Stuart, Florida", "locations": [ { "city": "Stuart", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02296567" }, { "nct_id": "NCT06972303", "title": "Mindfulness Meditation for Insomnia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sleep Initiation and Maintenance Disorders", "Insomnia", "Insomnia Chronic", "Mindfulness", "Telemedicine" ], "interventions": [ { "name": "Instructed bedtime app-guided mindfulness meditation", "type": "BEHAVIORAL" }, { "name": "Uninstructed app-guided mindfulness meditation", "type": "BEHAVIORAL" }, { "name": "Sleep hygiene education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-03-31", "completion_date": "2028-12-29", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06972303" }, { "nct_id": "NCT01250262", "title": "Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Back Pain", "Obesity" ], "interventions": [ { "name": "normal medical care and follow up", "type": "OTHER" }, { "name": "Isolated Lumbar Resistance Exercise Program", "type": "OTHER" }, { "name": "Total Body Resistance Exercise Program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 72, "start_date": "2010-11", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01250262" }, { "nct_id": "NCT02563327", "title": "Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tuberculosis" ], "interventions": [ { "name": "Rifapentine", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Pyridoxine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2516, "start_date": "2016-01-25", "completion_date": "2021-08-30", "has_results": true, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02563327" }, { "nct_id": "NCT01352182", "title": "Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Severe Sepsis", "Septic Shock" ], "interventions": [ { "name": "Pioglitazone hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12, "start_date": "2011-10", "completion_date": "2017-01", "has_results": true, "last_update_posted_date": "2020-09-02", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01352182" }, { "nct_id": "NCT03032250", "title": "Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Caregiver", "Malignant Head and Neck Neoplasm", "Paranasal Sinus Squamous Cell Carcinoma", "Salivary Gland Squamous Cell Carcinoma", "Stage I Hypopharyngeal Squamous Cell Carcinoma", "Stage I Laryngeal Squamous Cell Carcinoma", "Stage I Lip and Oral Cavity Squamous Cell Carcinoma", "Stage I Oropharyngeal Squamous Cell Carcinoma", "Stage II Hypopharyngeal Squamous Cell Carcinoma", "Stage II Laryngeal Squamous Cell Carcinoma", "Stage II Lip and Oral Cavity Squamous Cell Carcinoma", "Stage II Oropharyngeal Squamous Cell Carcinoma", "Stage III Hypopharyngeal Squamous Cell Carcinoma", "Stage III Laryngeal Squamous Cell Carcinoma", "Stage III Lip and Oral Cavity Squamous Cell Carcinoma", "Stage III Oropharyngeal Squamous Cell Carcinoma", "Stage IV Hypopharyngeal Squamous Cell Carcinoma", "Stage IV Laryngeal Squamous Cell Carcinoma", "Stage IV Lip and Oral Cavity Squamous Cell Carcinoma", "Stage IV Oropharyngeal Squamous Cell Carcinoma", "Stage IVA Hypopharyngeal Squamous Cell Carcinoma", "Stage IVA Laryngeal Squamous Cell Carcinoma", "Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma", "Stage IVA Oropharyngeal Squamous Cell Carcinoma", "Stage IVB Hypopharyngeal Squamous Cell Carcinoma", "Stage IVB Laryngeal Squamous Cell Carcinoma", "Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma", "Stage IVB Oropharyngeal Squamous Cell Carcinoma", "Stage IVC Hypopharyngeal Squamous Cell Carcinoma", "Stage IVC Laryngeal Squamous Cell Carcinoma", "Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma", "Stage IVC Oropharyngeal Squamous Cell Carcinoma", "Recurrent Head and Neck Squamous Cell Carcinoma", "Recurrent Hypopharyngeal Squamous Cell Carcinoma", "Recurrent Laryngeal Squamous Cell Carcinoma", "Recurrent Lip and Oral Cavity Squamous Cell Carcinoma", "Recurrent Oropharyngeal SCC", "Recurrent Paranasal Sinus Squamous Cell Carcinoma" ], "interventions": [ { "name": "Communication Intervention", "type": "OTHER" }, { "name": "Watch video", "type": "OTHER" }, { "name": "Module completion of the Prepare to Care kit", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Salivary cortisol collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2017-05-15", "completion_date": "2020-04-10", "has_results": true, "last_update_posted_date": "2023-01-09", "last_synced_at": "2026-11-06T16:51:18.990Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03032250" } ] }